SEC Form 4 · accession 0001185185-15-002807
U.S. Stem Cell, Inc. · USRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William P Murphy Jr.
Director · 10% Owner
Period of report
Nov 3, 2015
Accepted (ET)
Nov 6, 2015 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388319
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 3, 2015 | P$0 | 8,740 | — | A | 39,924 | D | |
| Common StockF2 | Nov 4, 2015 | P$0 | 226 | — | A | 40,150 | D | |
| Common Stock | holding | — | — | — | 5,171 | I | Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1$0.0015 - $0.00285 (price at pre-split level; number of shares calculated post-split)
- F2$4.50 - $7.50 (post-split price)